Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $215.43 | 52 Week High | $333.65 | |||
| Open | $215.43 | 52 Week Low | $223.02 | |||
| Day High | $215.43 | P/E | 27.58 | |||
| Day Low | $215.43 | EPS | $7.81 | |||
| Volume | 392 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 41.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.69 | 52 Week High | $26.84 | |||
| Open | $41.69 | 52 Week Low | $9.51 | |||
| Day High | $41.69 | P/E | N/A | |||
| Day Low | $41.69 | EPS | $-2.62 | |||
| Volume | 328 | |||||
